BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22004366)

  • 1. Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis.
    Li L; Zhang J; Liu X; Li X; Jiao B; Kang T
    J Gastroenterol Hepatol; 2012 Jan; 27(1):51-8. PubMed ID: 22004366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is radiofrequency ablation equal to surgical re-resection for recurrent hepatocellular carcinoma meeting the Milan criteria? A meta-analysis.
    Zhang CS; Zhang JL; Li XH; Li L; Li X; Zhou XY
    J BUON; 2015; 20(1):223-30. PubMed ID: 25778320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
    Dong W; Zhang T; Wang ZG; Liu H
    World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.
    Huang J; Yan L; Cheng Z; Wu H; Du L; Wang J; Xu Y; Zeng Y
    Ann Surg; 2010 Dec; 252(6):903-12. PubMed ID: 21107100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.
    Feng K; Yan J; Li X; Xia F; Ma K; Wang S; Bie P; Dong J
    J Hepatol; 2012 Oct; 57(4):794-802. PubMed ID: 22634125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials.
    Fu C; Liu N; Deng Q; Li X; Ma K; Bie P
    Hepatogastroenterology; 2014 Sep; 61(134):1722-9. PubMed ID: 25436369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Liu Z; Zhou Y; Zhang P; Qin H
    Surg Laparosc Endosc Percutan Tech; 2010 Jun; 20(3):130-40. PubMed ID: 20551807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
    Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
    J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
    Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi K; Yamamoto Y; Hasebe A; Ichikawa S; Yano M; Miyamoto Y; Ninomiya T; Otomi Y; Kokame M; Iwamura T; Ishimaru Y; Sogabe I; Kashihara K; Nishiura S; Ootani H; Takamura K; Kawasaki H
    Hepatogastroenterology; 2008; 55(88):2171-4. PubMed ID: 19260499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.